Understand Current and Future Use of Intensity-Modulated Radiation Therapy

Research and Markets (http://www.researchandmarkets.com/reports/c89974) has announced the addition of “Radiation Oncology Equipment Assessment: A Survey of Twenty-Seven US-based Radiation Oncologists” to their offering.

Deliverable: Survey with key findings

Study Description

Topic

– Radiation Oncology Equipment Assessment

Respondent Type

– Physicians

Specialties Covered

– US-based radiation oncologists

Region

– United States Only

Methodology

– Online survey, self-administered via a Panel Intelligence website

– Duration: 30 minutes

– Size: 27 respondents

Objectives: To understand current and future use of intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic radiosurgery, adaptive radiotherapy, and proton therapy.

– Evaluate the market outlook for several manufacturers including Accuray, Elekta, Siemens Medical, TomoTherapy, and Varian Medical.

– Determine drivers of growth for intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic radiosurgery, and adaptive radiotherapy.

– Examine the purchasing decision criteria for Varian’s new product line including VMAT and DART™.

– Assess the outlook for proton therapy.

Inclusion Criteria and Respondent Demographics

– US-based

– Board-certified or board-eligible in specialty

– 2 to 30 years of experience post-training

– Minimum of 50% professional time spent in clinical practice

– Familiar with manufacturers and products

For more information visit http://www.researchandmarkets.com/reports/c89974.